NEWS
CONFERENCES
MEDIA
PUBLICATIONS
CASE-BASED ROUNDTABLE
PARTNERS
RESOURCES
SUBSCRIBE

This roundtable series considers treatment options in the metastatic bladder cancer setting, as discussed by key opinion leaders and participants at virtual live events.

Using Targeted Treatments in Patients With Metastatic Urothelial Cancer

Physicians Discuss Sequencing of Sacituzumab Govitecan in Bladder Cancer

Physicians Discuss Sequencing of Sacituzumab Govitecan in Bladder Cancer

During a Targeted Oncology™ Case-Based Roundtable™ event, Pedro C. Barata, MD, MSc, and participants discussed when in sequence they would use sacituzumab govitecan for patients with metastatic urothelial cancer. This is the second of 2 articles based on this event.

Sacituzumab Govitecan Shows Efficacy in Pretreated Urothelial Cancer

Sacituzumab Govitecan Shows Efficacy in Pretreated Urothelial Cancer

During a Targeted Oncology™ Case-Based Roundtable™ event, Pedro C. Barata, MD, MSc, discussed data supporting the use of sacituzumab govitecan in advanced urothelial carcinoma.